Oomen-De Hoop E - Search Results

1

Locoregional control and survival after lymph node SBRT in oligometastatic disease.

Loi M, Frelinghuysen M, Klass ND, Oomen-De Hoop E, Granton PV, Aerts J, Verhoef C, Nuyttens J. Loi M, et al. Clin Exp Metastasis. 2018 Oct;35(7):625-633. doi: 10.1007/s10585-018-9922-x. Epub 2018 Jul 11. Clin Exp Metastasis. 2018. PMID: 29995254 Free PMC article.

2

Normal Tissue Complication Probability Modeling of Pulmonary Toxicity After Stereotactic and Hypofractionated Radiation Therapy for Central Lung Tumors.

Tekatli H, Duijm M, Oomen-de Hoop E, Verbakel W, Schillemans W, Slotman BJ, Nuyttens JJ, Senan S. Tekatli H, et al. Int J Radiat Oncol Biol Phys. 2018 Mar 1;100(3):738-747. doi: 10.1016/j.ijrobp.2017.11.022. Epub 2017 Nov 21. Int J Radiat Oncol Biol Phys. 2018. PMID: 29413285

3

Esophagus toxicity after stereotactic and hypofractionated radiotherapy for central lung tumors: Normal tissue complication probability modeling.

Duijm M, Tekatli H, Oomen-de Hoop E, Verbakel W, Schillemans W, Slotman BJ, Senan S, Nuyttens JJ. Duijm M, et al. Radiother Oncol. 2018 May;127(2):233-238. doi: 10.1016/j.radonc.2018.02.004. Epub 2018 Mar 2. Radiother Oncol. 2018. PMID: 29478763

4

Factors affecting local control of pulmonary oligometastases treated with stereotactic body radiotherapy.

Sharma A, Duijm M, Oomen-de Hoop E, Aerts JG, Verhoef C, Hoogeman M, Nuyttens JJ. Sharma A, et al. Acta Oncol. 2018 Aug;57(8):1031-1037. doi: 10.1080/0284186X.2018.1445285. Epub 2018 Feb 28. Acta Oncol. 2018. PMID: 29488414

5

Association between single-nucleotide polymorphisms and adverse events in nivolumab-treated non-small cell lung cancer patients.

Bins S, Basak EA, El Bouazzaoui S, Koolen SLW, Oomen-de Hoop E, van der Leest CH, van der Veldt AAM, Sleijfer S, Debets R, van Schaik RHN, Aerts JGJV, Mathijssen RHJ. Bins S, et al. Br J Cancer. 2018 May;118(10):1296-1301. doi: 10.1038/s41416-018-0074-1. Epub 2018 Apr 26. Br J Cancer. 2018. PMID: 29695768 Free PMC article.

6

Survival and prognostic factors of pulmonary oligometastases treated with stereotactic body radiotherapy.

Sharma A, Duijm M, Oomen-de Hoop E, Aerts JG, Verhoef C, Hoogeman M, Nuyttens JJ. Sharma A, et al. Acta Oncol. 2019 Jan;58(1):74-80. doi: 10.1080/0284186X.2018.1521986. Epub 2018 Oct 3. Acta Oncol. 2019. PMID: 30280633

7

Correlation between nivolumab exposure and treatment outcomes in non-small-cell lung cancer.

Basak EA, Koolen SLW, Hurkmans DP, Schreurs MWJ, Bins S, Oomen-de Hoop E, Wijkhuijs AJM, Besten ID, Sleijfer S, Debets R, van der Veldt AAM, Aerts JGJV, Mathijssen RHJ. Basak EA, et al. Eur J Cancer. 2019 Mar;109:12-20. doi: 10.1016/j.ejca.2018.12.008. Epub 2019 Jan 14. Eur J Cancer. 2019. PMID: 30654225

8

Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial.

Buisman FE, Homs MYV, Grünhagen DJ, Filipe WF, Bennink RJ, Besselink MGH, Borel Rinkes IHM, Bruijnen RCG, Cercek A, D'Angelica MI, van Delden OM, Donswijk ML, van Doorn L, Doornebosch PG, Emmering J, Erdmann JI, IJzerman NS, Grootscholten C, Hagendoorn J, Kemeny NE, Kingham TP, Klompenhouwer EG, Kok NFM, Koolen S, Kuhlmann KFD, Kuiper MC, Lam MGE, Mathijssen RHJ, Moelker A, Oomen-de Hoop E, Punt CJA, Te Riele WW, Roodhart JML, Swijnenburg RJ, Prevoo W, Tanis PJ, Vermaas M, Versleijen MWJ, Veuger FP, Weterman MJ, Verhoef C, Groot Koerkamp B. Buisman FE, et al. BMC Cancer. 2019 Apr 5;19(1):327. doi: 10.1186/s12885-019-5515-6. BMC Cancer. 2019. PMID: 30953467 Free PMC article.

9

Predicting High-Grade Esophagus Toxicity After Treating Central Lung Tumors With Stereotactic Radiation Therapy Using a Normal Tissue Complication Probability Model.

Duijm M, van der Voort van Zyp NC, van de Vaart P, Oomen-de Hoop E, Mast ME, Hoogeman MS, Nuyttens JJ. Duijm M, et al. Int J Radiat Oncol Biol Phys. 2020 Jan 1;106(1):73-81. doi: 10.1016/j.ijrobp.2019.08.059. Epub 2019 Sep 6. Int J Radiat Oncol Biol Phys. 2020. PMID: 31499137

10

Prognostic factors for local control and survival for inoperable pulmonary colorectal oligometastases treated with stereotactic body radiotherapy.

Sharma A, Baker S, Duijm M, Oomen-de Hoop E, Cornelissen R, Verhoef C, Hoogeman M, Jan Nuyttens J. Sharma A, et al. Radiother Oncol. 2020 Mar;144:23-29. doi: 10.1016/j.radonc.2019.10.004. Epub 2019 Nov 9. Radiother Oncol. 2020. PMID: 31710940

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

83 results

Search Page